HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development

In this study, we compared the overall gene and pathway expression profiles of HS-5 and HS-27A stromal cell lines with those of primary bone marrow MSCs to verify if they can be considered a reliable alternative tool for evaluating the contribution of MSCs in tumor development and immunomodulation....

Full description

Bibliographic Details
Main Authors: Annalisa Adamo, Pietro Delfino, Alessandro Gatti, Alice Bonato, Paul Takam Kamga, Riccardo Bazzoni, Stefano Ugel, Angela Mercuri, Simone Caligola, Mauro Krampera
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2020.584232/full
id doaj-174f9adbc6584bdcab153c29fab8ca07
record_format Article
spelling doaj-174f9adbc6584bdcab153c29fab8ca072020-11-25T04:08:37ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-11-01810.3389/fcell.2020.584232584232HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer DevelopmentAnnalisa Adamo0Annalisa Adamo1Pietro Delfino2Alessandro Gatti3Alice Bonato4Paul Takam Kamga5Paul Takam Kamga6Riccardo Bazzoni7Stefano Ugel8Angela Mercuri9Simone Caligola10Mauro Krampera11Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyDepartment of Medicine, Section of Immunology, University of Verona, Verona, ItalyDepartment of Diagnostic and Public Health, University of Verona, Verona, ItalyStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyEA4340-BCOH, Biomarker in Cancerology and Onco-Haematology, UVSQ, Université Paris Saclay, Boulogne-Billancourt, FranceStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyDepartment of Medicine, Section of Immunology, University of Verona, Verona, ItalyStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyDepartment of Medicine, Section of Immunology, University of Verona, Verona, ItalyStem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, ItalyIn this study, we compared the overall gene and pathway expression profiles of HS-5 and HS-27A stromal cell lines with those of primary bone marrow MSCs to verify if they can be considered a reliable alternative tool for evaluating the contribution of MSCs in tumor development and immunomodulation. Indeed, due to their easier manipulation in vitro as compared to primary MSC cultures, several published studies took advantage of stromal cell lines to assess the biological mechanisms mediated by stromal cells in influencing tumor biology and immune responses. However, the process carried out to obtain immortalized cell lines could profoundly alter gene expression profile, and consequently their biological characteristics, leading to debatable results. Here, we evaluated the still undisclosed similarities and differences between HS-5, HS-27A cell lines and primary bone marrow MSCs in the context of tumor development and immunomodulation. Furthermore, we assessed by standardized immunological assays the capability of the cell lines to reproduce the general mechanisms of MSC immunoregulation. We found that only HS-5 cell line could be suitable to reproduce not only the MSC capacity to influence tumor biology, but also to evaluate the molecular mechanisms underlying tumor immune escape mediated by stroma cells. However, HS-5 pre-treatment with inflammatory cytokines, that normally enhances the immunosuppressive activity of primary MSCs, did not reproduce the same MSCs behavior, highlighting the necessity to accurately set up in vitro assays when HS-5 cell line is used instead of its primary counterpart.https://www.frontiersin.org/articles/10.3389/fcell.2020.584232/fullmesenchymal stromal cellsstromal cell linestumor biologyimmunomodulationtumor escape
collection DOAJ
language English
format Article
sources DOAJ
author Annalisa Adamo
Annalisa Adamo
Pietro Delfino
Alessandro Gatti
Alice Bonato
Paul Takam Kamga
Paul Takam Kamga
Riccardo Bazzoni
Stefano Ugel
Angela Mercuri
Simone Caligola
Mauro Krampera
spellingShingle Annalisa Adamo
Annalisa Adamo
Pietro Delfino
Alessandro Gatti
Alice Bonato
Paul Takam Kamga
Paul Takam Kamga
Riccardo Bazzoni
Stefano Ugel
Angela Mercuri
Simone Caligola
Mauro Krampera
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
Frontiers in Cell and Developmental Biology
mesenchymal stromal cells
stromal cell lines
tumor biology
immunomodulation
tumor escape
author_facet Annalisa Adamo
Annalisa Adamo
Pietro Delfino
Alessandro Gatti
Alice Bonato
Paul Takam Kamga
Paul Takam Kamga
Riccardo Bazzoni
Stefano Ugel
Angela Mercuri
Simone Caligola
Mauro Krampera
author_sort Annalisa Adamo
title HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
title_short HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
title_full HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
title_fullStr HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
title_full_unstemmed HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development
title_sort hs-5 and hs-27a stromal cell lines to study bone marrow mesenchymal stromal cell-mediated support to cancer development
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2020-11-01
description In this study, we compared the overall gene and pathway expression profiles of HS-5 and HS-27A stromal cell lines with those of primary bone marrow MSCs to verify if they can be considered a reliable alternative tool for evaluating the contribution of MSCs in tumor development and immunomodulation. Indeed, due to their easier manipulation in vitro as compared to primary MSC cultures, several published studies took advantage of stromal cell lines to assess the biological mechanisms mediated by stromal cells in influencing tumor biology and immune responses. However, the process carried out to obtain immortalized cell lines could profoundly alter gene expression profile, and consequently their biological characteristics, leading to debatable results. Here, we evaluated the still undisclosed similarities and differences between HS-5, HS-27A cell lines and primary bone marrow MSCs in the context of tumor development and immunomodulation. Furthermore, we assessed by standardized immunological assays the capability of the cell lines to reproduce the general mechanisms of MSC immunoregulation. We found that only HS-5 cell line could be suitable to reproduce not only the MSC capacity to influence tumor biology, but also to evaluate the molecular mechanisms underlying tumor immune escape mediated by stroma cells. However, HS-5 pre-treatment with inflammatory cytokines, that normally enhances the immunosuppressive activity of primary MSCs, did not reproduce the same MSCs behavior, highlighting the necessity to accurately set up in vitro assays when HS-5 cell line is used instead of its primary counterpart.
topic mesenchymal stromal cells
stromal cell lines
tumor biology
immunomodulation
tumor escape
url https://www.frontiersin.org/articles/10.3389/fcell.2020.584232/full
work_keys_str_mv AT annalisaadamo hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT annalisaadamo hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT pietrodelfino hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT alessandrogatti hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT alicebonato hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT paultakamkamga hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT paultakamkamga hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT riccardobazzoni hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT stefanougel hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT angelamercuri hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT simonecaligola hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
AT maurokrampera hs5andhs27astromalcelllinestostudybonemarrowmesenchymalstromalcellmediatedsupporttocancerdevelopment
_version_ 1724424793045860352